CoChat

Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa

Shiha, Gamal, Alswat, Khalid, Al Khatry, Maryam, Sharara, Ala I, Örmeci, Necati, Waked, Imam, Benazzouz, Mustapha, Al-Ali, Fuad, Hamed, Abd Elkhalek, Hamoudi, Waseem, Attia, Dina, Derbala, Moutaz, Sharaf-Eldin, Mohamed, Al-Busafi, Said A, Zaky, Samy, Bamakhrama, Khaled, Ibrahim, Nazir, Ajlouni, Yousef, Sabbah, Meriam, Salama, Mohsen, Anushiravani, Amir, Afredj, Nawel, Barakat, Salma, Hashim, Almoutaz, Fouad, Yasser, Soliman, Reham · 2021 · The Lancet Gastroenterology & Hepatology
Cited by 153

The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.

Abstract

With the increasing prevalence of obesity and type 2 diabetes, fatty liver disease associated with metabolic dysfunction is a global health problem, especially because it is one of the earliest consequences of obesity and it precedes diabetes development. Fatty liver disease associated with metabolic dysfunction is of particular concern in the Middle East and north Africa, where its prevalence is greater than that in the rest of the world. Despite the magnitude of the problem, no regional guidelines have been developed to address this disease. This Review describes suggestions of redefining fatty liver disease associated with metabolic dysfunction, including its terminology and criteria for diagnosis. Experts have raised serious concerns on the current nomenclature, which labels the disease as non-alcoholic fatty liver disease (NAFLD), and its diagnostic criteria. The panel reached a consensus that the disease should be renamed as metabolic-associated fatty liver disease (MAFLD) and that the disease should be diagnosed by positive criteria. The aim is now to work with authorities across the region to implement these proposed changes and reflect them in health-care policy and to improve health care for patients in this region.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s2468-1253(20)30213-2

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 9 references

Cited by

See all 153

Metadata

Authors
Shiha, G., Alswat, K., Al Khatry, M., Sharara, A. I., Örmeci, N., Waked, I., Benazzouz, M., Al-Ali, F., Hamed, A. E., Hamoudi, W., Attia, D., Derbala, M., Sharaf-Eldin, M., Al-Busafi, S. A., Zaky, S., Bamakhrama, K., Ibrahim, N., Ajlouni, Y., Sabbah, M., Salama, M., Anushiravani, A., Afredj, N., Barakat, S., Hashim, A., Fouad, Y., & Soliman, R.
Venue
The Lancet Gastroenterology & Hepatology
Publisher
Elsevier BV
Published
2021-01
Volume
6
Issue
1
Pages
57-64
ISSN
  • 2468-1156 (ISSN-L)
  • 2468-1253
OpenAlex
W3099597731
Cited by
153
References
9
FWCI
18.28
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa. https://app.cochat.ai/papers/10.1016/s2468-1253(20)30213-2
The paper
Shiha, G., Alswat, K., Al Khatry, M., Sharara, A. I., Örmeci, N., Waked, I., Benazzouz, M., Al-Ali, F., Hamed, A. E., Hamoudi, W., Attia, D., Derbala, M., Sharaf-Eldin, M., Al-Busafi, S. A., Zaky, S., Bamakhrama, K., Ibrahim, N., Ajlouni, Y., Sabbah, M., . . . Soliman, R. (2021). Nomenclature and definition of metabolic-associated fatty liver disease: a consensus from the Middle East and north Africa. The Lancet Gastroenterology & Hepatology. https://doi.org/10.1016/s2468-1253(20)30213-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.